Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents

Abstract Background Coronary artery aneurysms after drug eluting stents are rare. We present a case series of type II coronary aneurysms after implantation of Everolimus eluting stents including patients developing giant aneurysms with a toxic course. Case presentation Over a span of 3.5 years at ou...

Full description

Bibliographic Details
Main Authors: Raghav Sharma, Aditya Vikram Ruia, Tek Singh Mahant
Format: Article
Language:English
Published: BMC 2022-02-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-022-02503-1
_version_ 1818280313092046848
author Raghav Sharma
Aditya Vikram Ruia
Tek Singh Mahant
author_facet Raghav Sharma
Aditya Vikram Ruia
Tek Singh Mahant
author_sort Raghav Sharma
collection DOAJ
description Abstract Background Coronary artery aneurysms after drug eluting stents are rare. We present a case series of type II coronary aneurysms after implantation of Everolimus eluting stents including patients developing giant aneurysms with a toxic course. Case presentation Over a span of 3.5 years at our center 2572 patients were implanted Everolimus eluting stents out of which 4 patients developed coronary type II aneurysms an incidence of 0.00156 whereas 5838 patients were implanted Sirolimus eluting 2nd generation stents out of which 2 patients developed similar aneurysms with an incidence of 0.00034. The slight increase in incidence in Everolimus stents does not reach statistical significance (p = 0.054) and is limited by single centre non randomized study. We also propose a hypothesis that the slight increase in the incidence maybe due to allergy to Methacrylate present in Everolimus eluting Xience stent’s primer which is absent in other Sirolimus eluting stents used at our center but that needs to be further investigated. We also found some patients who developed giant aneurysms including Left main aneurysms. In our series operative repair of these patients had better outcomes than covered stent deployment but larger trials maybe needed to confirm the same. Conclusions Coronary artery aneurysms after stent implantation are rare but occasionally giant aneurysms are formed with a toxic course. The incidence and morphology of aneurysms after Everolimus and Sirolimus eluting stent deployment do not differ much.
first_indexed 2024-12-12T23:47:14Z
format Article
id doaj.art-7994d175cfeb4ff8a9a3d3a5630130dc
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-12T23:47:14Z
publishDate 2022-02-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-7994d175cfeb4ff8a9a3d3a5630130dc2022-12-22T00:06:49ZengBMCBMC Cardiovascular Disorders1471-22612022-02-0122111110.1186/s12872-022-02503-1Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stentsRaghav Sharma0Aditya Vikram Ruia1Tek Singh Mahant2Interventional Cardiologist, HOD Cardiology Unit, Meditrina Hospital (Civil Hospital)Interventional Cardiologist, HOD Cardiology Unit, Meditrina Hospital (Civil Hospital)Senior Cardiothoracic Surgeon, Executive Director Cardiac Surgery, Fortis Healthcare HospitalAbstract Background Coronary artery aneurysms after drug eluting stents are rare. We present a case series of type II coronary aneurysms after implantation of Everolimus eluting stents including patients developing giant aneurysms with a toxic course. Case presentation Over a span of 3.5 years at our center 2572 patients were implanted Everolimus eluting stents out of which 4 patients developed coronary type II aneurysms an incidence of 0.00156 whereas 5838 patients were implanted Sirolimus eluting 2nd generation stents out of which 2 patients developed similar aneurysms with an incidence of 0.00034. The slight increase in incidence in Everolimus stents does not reach statistical significance (p = 0.054) and is limited by single centre non randomized study. We also propose a hypothesis that the slight increase in the incidence maybe due to allergy to Methacrylate present in Everolimus eluting Xience stent’s primer which is absent in other Sirolimus eluting stents used at our center but that needs to be further investigated. We also found some patients who developed giant aneurysms including Left main aneurysms. In our series operative repair of these patients had better outcomes than covered stent deployment but larger trials maybe needed to confirm the same. Conclusions Coronary artery aneurysms after stent implantation are rare but occasionally giant aneurysms are formed with a toxic course. The incidence and morphology of aneurysms after Everolimus and Sirolimus eluting stent deployment do not differ much.https://doi.org/10.1186/s12872-022-02503-1Coronary artery aneurysmXience stentMethacrylateGiant aneurysmLeft main aneurysmCase report
spellingShingle Raghav Sharma
Aditya Vikram Ruia
Tek Singh Mahant
Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
BMC Cardiovascular Disorders
Coronary artery aneurysm
Xience stent
Methacrylate
Giant aneurysm
Left main aneurysm
Case report
title Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
title_full Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
title_fullStr Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
title_full_unstemmed Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
title_short Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
title_sort case series of coronary artery aneurysms after everolimus eluting stent implantation and comparison with sirolimus eluting stents
topic Coronary artery aneurysm
Xience stent
Methacrylate
Giant aneurysm
Left main aneurysm
Case report
url https://doi.org/10.1186/s12872-022-02503-1
work_keys_str_mv AT raghavsharma caseseriesofcoronaryarteryaneurysmsaftereverolimuselutingstentimplantationandcomparisonwithsirolimuselutingstents
AT adityavikramruia caseseriesofcoronaryarteryaneurysmsaftereverolimuselutingstentimplantationandcomparisonwithsirolimuselutingstents
AT teksinghmahant caseseriesofcoronaryarteryaneurysmsaftereverolimuselutingstentimplantationandcomparisonwithsirolimuselutingstents